Disruption has arrived for ‘big pharma’
21 December 2017Candesic's Dr Niklas Jahn and Dr Michelle Tempest suggest a silver lining for investors in the drug discovery and biotech…Personalised pharmacotherapy – who is it good for?
1 October 2017Dr Joe Taylor considers the implications of personalised pharmacotherapy for life sciences and healthcare.
Immunotherapy: A new weapon against cancer
1 June 2015Candesic's Dr Robert Watson and Dr Michelle Tempest discuss medical advances in cancer treatment. They explain medical terminology and how…
